News

UCSB News Release: "KetoCitra is Here: A long-awaited medical food developed for patients with Polycystic Kidney Disease (PKD) is now available"

November 29, 2021

KetoCitra is Here
A long-awaited medical food developed for patients with Polycystic Kidney Disease (PKD) is now available

By Sonia Fernandez
Monday, November 29, 2021 - 16:30, Santa Barbara, CA

Related Links

Link to UCSB News Release

Our retrospective case series study just published (in press but available online).

September 15, 2021

Congratulations to all authors!

Strubl S, Oehm S, Torres JA, Grundmann F, Haratani J, Decker M, Vuong S, Bhandal AK, Methot N, Haynie-Cion R, Meyer F, Siedek F, Korst U, Müller RU, Weimbs T. Ketogenic Dietary Interventions in Autosomal-Dominant Polycystic Kidney Disease (ADPKD)– A Retrospective Case Series Study: First insights into Feasibility, Safety and Effects. Clinical Kidney Journal (in press). 2021

Webinar on "Healthy Diet, Intermittent Fasting and PKD", PKD Education Series

August 28, 2021

Sponsored by PKD Foundation of Canada

Related Links

Link to webinar

Conference talk at National Kidney Foundation

April 24, 2021

Diana Bruen, RDN, and Dr. Weimbs gave a presentation titled "New Insights for Nutritional Interventions for Polycystic Kidney Disease" at the recent Spring Clinical Meetings SCM21 conference of the National Kidney Foundation.

Related Links

Link to program

New URCA grants for Weimbs Lab undergraduates

February 06, 2021

Congratulations to the following undergraduate students who have all been awarded Undergraduate Research and Creative Activities (URCA) Grants to support independent research projects in the Weimbs lab. Each grant comes with $750 to support lab research. The grants are to support various research projects on polycystic kidney disease that are going on in the lab.

Congratulations to Julia Sergejeva, Claudia Do, Adriana Getman, Juliette Rebello, and Miles Ellman !

Latest paper from lab published. Congratulations to all authors!

December 10, 2020

Giovannone AJ, Reales E, Bhattaram P, Nackeeran S, Monahan AB, Syed R, Weimbs T. The Habc domain of syntaxin 3 is a ubiquitin binding domain. Sci Rep. 2020;10(1):21350.

Related Links

Link to paper

Collaborative paper with Dr. Max Liebau published

October 28, 2020

Dafinger C, Mandel AM, Braun A, Göbel H, Burgmaier K, Massella L, Mastrangelo A, Dötsch J, Benzing T, Weimbs T, Schermer B, Liebau MC. The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation. J Cell Mol Med. 2020 Oct 28. doi: 10.1111/jcmm.16014. Epub ahead of print. PMID: 33112055.

Related Links

Link to paper

New research grant from the Department of Defense

August 21, 2020

Dr. Weimbs was awarded a research grant from the Department of Defense (Peer Reviewed Medical Research Program, Investigator-Initiated Research Award). The title of the study is "Ketosis as a therapy for polycystic kidney disease".

New grant to conduct clinical trial in polycystic kidney disease

June 05, 2020

THE PKD FOUNDATION AWARDED A GRANT TO ROMAN-ULRICH MÜLLER, M.D. AND THOMAS WEIMBS, PH.D.

to conduct a clinical trial titled: "KETO-ADPKD — A pilot trial of ketogenic dietary interventions in ADPKD". This pilot and feasibility trial will be conducted at the University Hospital in Cologne, Germany.

Review article published in "Cellular Signaling"

April 27, 2020

Pages

More...

Facebook Twitter LinkedIn